A great indicator that a sectors entering the “Hoit Zone” is new ETFs springing up and this has happened in the weight loss space with HRTS, OZEM and THNR three relatively new listings in the US. This ETFs three largest holdings, out of 44, are Eli Lilly, Abbott Laboratories and AstraZeneca; its benefitted from less than 4% being allocated to NVO.
- We feel the HRTS ETF is a coin toss ~ at $US28, with a test of $US a distinct possibility.
MM is neutral towards HRTS
Add To Hit List
